Rx Bandz, LLC SBIR Phase II Award, February 2023

A SBIR Phase II contract was awarded to Rx Bandz in February, 2023 for $1,249,908.0 USD from the U.S. Department of Defense and United States Air Force.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/2568347

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Rx Bandz

Government Agency

U.S. Department of Defense

Government Branch

United States Air Force

Award Type

SBIR0

Contract Number (US Government)

FA8649-23-P-04450

Award Phase

Phase II0

Award Amount (USD)

1,249,9080

Date Awarded

February 10, 2023

End Date

November 10, 2024

Abstract

Non-compressible hemorrhages are the leading cause of preventative deaths in the military. Tranexamic acid (TXA) is an injectable medication that has not only been proven to be highly effective in controlling non-compressible hemorrhages but also in redu